Clinical Trial Update: Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fungal prophylaxis with isavuconazole in patients undergoing allogeneic hematopoietic stem cell transplantation; the trial is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Myeloproliferative Disorder

Drugs mentioned

• Isavuconazole (Isavuconazole)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hematologic Malignancy, Myeloproliferative Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20